Abstract
Stem cells have been considered as a useful tool in Regenerative Medicine due to two main properties: high rate of self-renewal, and their potential to differentiate into all cell types present in the adult organism. Depending on their origin, these cells can be grouped into embryonic or adult stem cells. Embryonic stem cells are obtained from the inner cell mass of blastocyst, which appears during embryonic day 6 of human development. Adult stem cells are present within various tissues of the organism and are responsible for their turnover and repair. In this sense, these cells open new therapeutic possibilities to treat degenerative diseases such as type 1 diabetes. This pathology is caused by the autoimmune destruction of pancreatic β-cells, resulting in the lack of insulin production. Insulin injection, however, cannot mimic β-cell function, thus causing the development of important complications. The possibility of obtaining β-cell surrogates from either embryonic or adult stem cells to restore insulin secretion will be discussed in this review.
Similar content being viewed by others
Abbreviations
- ASCs:
-
adult stem cells
- BB rat:
-
biobreeding rat
- CHIBs:
-
cultivated human islet buds
- CMV:
-
cytomegalovirus
- EBs:
-
embryoid bodies
- EGF:
-
epidermal growth factor
- ESCs:
-
embryonic stem cells
- GFAP:
-
glial fibrillary acidic protein
- IGF:
-
insulin-like growth factor
- IPSCs:
-
islet pluripotent stem cells
- KGF:
-
keratinocyte growth factor
- LIF:
-
leukaemia inhibitory factor
- MAPCs:
-
multipotent adult progenitor cells
- NF-200:
-
neurofilament-200
- NIPs:
-
nestin-positive islet-derived progenitors
- NO:
-
nitric oxide
- NOD mouse:
-
nonobese diabetic mouse
- Pax4/6:
-
paired homeobox 4/6
- PC-2:
-
protein convertase 2
- Pdx1:
-
pancreatic duodenal homeobox 1
References
H.M. Blau, T.R. Brazelton and J.M. Weimann: “The evolving concept of a stem cell: Entity or function?”, Cell, Vol. 105, (2001), pp. 829–841.
J. Betschinger, K. Mechtler and J.A. Knoblich: “Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells”, Cell, Vol. 124, (2006), pp. 1241–1253.
R.P. Lanza, R. Langer and J. Vacanti: Principles of tissue engineering, 2nd ed., Academic Press, San Diego, 2000.
J.B. Gurdon, J.A. Byrne and S. Simonsson: “Nuclear reprogramming and stem cell creation”, Proc. Natl. Acad. Sci. USA, Vol. 100, (2003), pp. 11819–11822.
K. Hochedlinger and R. Jaenisch: “Nuclear transplantation, embryonic stem cells, and the potential for cell therapy”, New Engl. J. Med., Vol. 349, (2003), pp. 275–286.
M.J. Munsie, A.E. Michalska, C.M. O’Brien, A.O. Trounson, M.F. Pera and P.S. Mountford: “Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei”, Curr. Biol., Vol. 10, (2000), pp. 989–992.
T. Wakayama, V. Tabar, I. Rodriguez, A.C.F. Perry, L. Studer and P. Mombaerts: “Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer”, Science, Vol. 292, (2001), pp. 740–743.
I. Wilmut, N. Beaujean, P.A. de Sousa, A. Dinnyes, T.J. King, L.A. Paterson, D. N. Wells and L.E. Young: “Somatic cell nuclear transfer”, Nature, Vol. 419, (2002), pp. 583–586.
J.B. Cibelli, K.A. Grant, K.B. Chapman, K. Cunniff, T. Worst, H.L. Green, S. J. Walker, P.H. Gutin, L. Vilner, V. Tabar, T. Dominko, J. Kane, P.J. Wettstein, R.P. Lanza, L. Studer, K. E. Vrana and M.D. West: “Parthenogenetic stem cells in nonhuman primates”, Science, Vol. 295, (2002), pp. 819.
A. Trounson: “The genesis of embryonic stem cells. Does parthenogenesis offer a more promising means of developing immune-matched ES cells?”, Nat. Biotechnol., Vol. 20, (2002), pp. 237–238.
J. Pomerantz and H.M. Blau: “Nuclear reprogramming: A key to stem cell function in regenerative medicine”, Nat. Cell Biol., Vol. 9, (2004), pp. 810–816.
P.S. Western and M.A. Surani: “Nuclear reprogramming-alchemy or analysis?”, Nat. Biotechnol., Vol. 20, (2002), pp. 445–446.
J.S. Odorico, D.S. Kaufman and J.A. Thomson: “Multilineage differentiation from human embryonic stem cell lines”, Stem Cells, Vol. 19, (2001), pp. 193–204.
A.G. Smith: “Embryo-derived stem cells: Of mice and men”, Annu. Rev. Cell. Develop. Biol., Vol. 17, (2001), pp. 435–462.
R.A. DeFronzo, E. Ferrannini, H. Keen and P. Zimmet: International textbook of diabetes mellitus, John Wiley and Sons, Chichester, UK, 2004.
N. Wierup, S. Yang, R.J. McEvilly, H. Mulder and F. Sundler: “Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1(832/13) cells”, J. Histochem. Cytochem., Vol. 52, (2004), pp. 301–310.
R.S. Heller, M. Jenny, P. Collombat, A. Mansouri, C. Tomasetto, O.D. Madsen, G. Mellitzer, G. Gradwohl and P. Serup: “Genetic determinants of pancreatic epsiloncell development”, Dev. Biol., Vol. 286, (2005), pp. 217–224.
M.S. Rao and J.K. Reddy: “Pancreatic stem cells: differentiation options”, Stem Cell Rev., Vol. 1, (2005), pp. 265–272.
M. Brownlee: “Biochemistry and molecular cell biology of diabetic complications”, Nature, Vol. 414, (2001), pp. 813–820.
C. Benoist and D. Mathis: “Cell death mediators in autoimmune diabetes-No shortage of suspects”, Cell, Vol. 89, (1997), pp. 1–3.
D. Mathis, L. Vence and C. Benoist: “β-Cell death during progression to diabetes”, Nature, Vol. 414, (2001), pp 792–798.
E. Roche, J.A. Reig, A. Campos, B. Paredes, J.R. Isaac, S. Lim, R.Y. Calne and B. Soria: “Insulin-secreting cells derived from stem cells: Clinical perspectives, hypes and hopes”, Transpl. Immunol., Vol. 15, (2005), pp. 113–129.
P. Zimmet, K.G.M.M. Alberti and J. Shaw: “Global and societal implications of the diabetes epidemic”, Nature, Vol. 414, (2001), pp. 782–787.
A.M.J. Shapiro, J.R.T. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, G.L. Warnock, N.M. Kneteman and R.V. Rajotte: “Islet transplantation in seven patients with type 1 diabetes mellitus using a corticoid-free immunosuppressive regime”, New Engl. J. Med., Vol. 343, (2000), pp. 230–238.
B. Keymeulen, P. Gillard, C. Mathieu, B. Movahedi, G. Maleux, G. delvaux, D. Ysebaert, B. roep, E. Vandemeulebroucke, M. Marichal, P. In’t Veld, M. Bogdani, C. Hendrieckx, F. Gorus, Z. Ling, J. van Rood and D. Pipeleers: “Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft”, Proc. Natl. Acad. Sci. USA, Vol. 103, (2006), pp. 17444–17449.
A. Borjesson and C. Carlsson: “Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations of interleukin-1β”, J. Endocrinol., Vol. 192, (2007), pp. 381–387.
E.A. Ryan, B.W. Paty, P.A. Senor, D. Bigam, E. Alfadhli, N.M. Kneteman, J.R. Lakey and A.M. Shapiro: “Five-year follow-up alter clinical islet transplantation”, Diabetes, Vol. 54, (2005), pp. 2060–2069.
O. Korsgren, B. Nilsson, C. Berne, M. Felldin, A. Foss, R. Kallen, T. Lundgren, K. Salmela, A. Tibell and G. Tufveson: “Current status of clinical islet transplantation”, Transplantation, Vol. 79, (2005), 1289–1293.
E. Fuchs, T. Tumbar and G. Guasch: “Socializing with the neighbors: Stem cells and their niche”, Cell, Vol. 116, (2000), pp. 769–778.
R. Ensenat-Waser, A. Santana, N. Vicente-Salar, J.C. Cigudosa, E. Roche, B. Soria and J.A. Reig: “Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking”, In Vitro Cell. Dev. Biol.-Animal, Vol. 42, (2006), pp. 115–123.
C. Holden and G. Vogel: “Cell biology. A technical fix for an ethical bind?”, Science, Vol. 306, (2004), 2174–2176.
J.T. Do and H.R. Schöler: “Nuclei of embryonic stem cells reprogram somatic cells”, Stem Cells, Vol. 22, (2004), pp. 941–949.
A. J. Wagers and I.L. Weissman: “Plasticity of adult stem cells”, Cell, Vol. 116, (2004), pp. 639–648.
C.S. Potten and M. Loeffler: “Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt”, Development, Vol. 110, (1990), pp. 1001–1020.
S. Bonner-Weir, M. Taneja, G.C. Weir, K. Tatarkiewicz, K.-H. Song, A. Sharma and J.J. O’Neil: “In vitro cultivation of human islets from expanded ductal tissue”, Proc. Natl. Acad. Sci. USA, Vol. 97, (2000), pp. 7999–8004.
V.K. Ramiya, M. Maraist, K.E. Arfors, D.A. Schatz, A.B. Peck and J.G. Cornelius: “Reversal of insulin-dependent diabtes using islets generated in vitro from pancreatic stem cells”, Nat. Med., Vol. 6, (2000), pp. 278–282.
H. Zulewski, E.J. Abraham, M.J. Gerlach, P.B. Daniel, W. Moritzs, B. Müller, M. Vallejo, M.K. Thomas and J.F. Habener: “Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes”, Diabetes, Vol. 50, (2001), pp. 521–533.
L. Selander and H. Edlund: “Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas”, Mech. Dev., Vol. 113, (2002), pp. 189–192.
H. Huang and X. Tang: “Phenotypic determination and characterization of nestinpositive precursors derived from human fetal pancreas”, Lab. Invest., Vol. 83, (2003), pp. 539–547.
R.M. Seaberg, S.R. Smukler, T.J. Kieffer, G. Enikolopov, Z. Asghar, M.B. Wheeler, G. Korbutt and D. van der Kooy: “Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages”, Nat. Biotechnol., Vol. 22, (2004), pp. 1115–1124.
Y.H. Chou, S. Khuon, H. Hermann and R.D. Goldman: “Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis”, Mol. Biol. Cell, Vol. 14, (2003), pp. 1468–1478.
F. Esni, D.A. Stoffers, T. Takeuchi and S.D. Leach: “Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas”, Mech. Dev., Vol. 121, (2004), pp. 15–25.
T. Klein, Z. Ling, H. Heimberg, O.D. Madsen, R.S. Heller and P. Serup: “Nestin is expressed in vascular endothelial cells in the adult human pancreas”, J. Histochem. Cytochem., Vol. 51, (2003), pp. 697–706.
J. Lardon, I. Rooman and L. Bouwens: “Nestin expression in pancreatic stellate cells and angiogenic endothelial cells”, Histochem. Cell. Biol., Vol. 117, (2002), pp. 535–540.
M.C. Gershengorn, A.A. Hardikar, A. Hardikar, C. Wei, E. Geras-Raaka, B. Marcus-Samuels and B.M. Raaka: “Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells”, Science, Vol. 306, (2004), pp. 2261–2264.
U. Ahlgren, S.L. Plaff, T.M. Jessell, T. Edlund and H. Edlund: “Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells”, Nature, Vol. 385, (1997), pp. 257–260.
F. Atouf, C.H. Park, K. Pechhold, M. Ta, Y. Choi and N.L. Lumeelsky: “No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro”, Diabetes, Vol. 56, (2007), pp. 699–702.
L.G. Chase, F. Ulloa-Montoya, B.L. Kidder and C.M. Verfaille: “Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells”, Diabetes, Vol. 56, (2007), pp. 3–7.
M. Eberhardt, P. Salmon, M.A. von Mach, J.G. Hengstler, M. Brulport, P. Linscheid, D. Seboek, J. Oberholzer, A. Barbero, I. martin, B. Müller, D. Trono and H. Zulewski: “Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets”, Biochem. Biophys. Res. Commun., Vol. 345, (2006), pp. 1167–1176.
N. Weinberg, L. Ouziel-Yahalom, S. Knoller, S. Efrat and Y. Dor: “Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic betacells”, Diabetes, Vol. 56, (2007), pp. 1299–1304.
K.L. Seeberger, J.M Dufour, A.M. Shapiro, J.R. Lakey, R.V. Rajotte, G. S. Korbutt: “Expansion of mesenchymal stem cells from human pancreatic ductal epithelium”, Lab. Invest., Vol. 86, (2006), pp. 141–153.
K. Minami, M. Okuno, K. Miyawaki, A. Okumachi, K. Ishizaki, K. Oyama, M. Kawaguchi, N. Ishizuka, T. Iwanaga and S. Seino: “Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells”, Proc. Natl. Acad. Sci. USA, Vol. 102, (2005), pp. 15116–15121.
B.M. Desai, J. Oliver-Krasinski, D.D. De Leon, C. Fazard, N. Hong, S.D. Leach and D.A. Stoffers: “Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell regeneration”, J. Clin. Invest., Vol 117, (2007), pp. 971–977.
Y. Dor, J. Brown, O.I. Martínez and D.A. Melton: “Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation”, Nature, Vol. 429, (2004), pp. 41–46.
P. Serup: “Embryonic stem cell-based diabetes therapy-a long road to travel”, Diabetologia, Vol. 49, (2006), pp. 2537–2540.
M. Banerjee, M. Kanitkar and R.R. Bhonde: “Approaches towards endogenous pancreatic regeneration”, Rev. Diabet. Stud., Vol. 2, (2005), pp. 165–176.
S. Kodama, W. Kuhtreiber, S. Fujimura, E.A. Dale and D.L. Faustman: “Islet regeneration during the reversal of autoimmune diabetes in NOD mice”, Science, Vol. 302, (2003), pp. 1223–1227.
Z. Yang, M. Chen, J.D. Carter, C.S. Nunemaker, J.C. Garmey, S.D. Kimble and J.L. Nadler: “Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes”, Biochem. Biophys. Res. Commun., Vol. 344, (2006), pp. 1017–1022.
Y. Jiang, B.N. Jahagirdar, R.L. Reinhardt, R.E. Schwartz, C.D. Keene, X.R. Ortiz-González, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, J. Du, S. Aldrich, A. Lisberg, W.C. Lew, D.A. Largaespada and C.M. Verfaillie: “Pluripotency of mesenchymal stem cells derived from adult marrow”, Nature, Vol. 418, (2002), pp. 41–49.
A. Ianus, G.G. Holz, N.D. Theise and M.A. Hussain: “In vivo derivation of glucosecompetent pancreatic endocrine cells from bone marrow without evidence of cell fusion”, J. Clin. Invest., Vol. 111, (2003), pp. 843–850.
G. D’Ippolito, S. Diabira, G.A. Howard, P. Menei, B.A. Roos and P.C. Schiller: “Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential”, J. Cell. Sci., Vol. 117, (2004), pp. 2971–2981.
T. Tayaramma, B. Ma, M. Rohde and H. Mayer: “Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells”, Stem Cells, Vol. 24, (2006), pp. 2858–2867.
C. Moriscot, F. De Fraipont, M.-J. Richard, M. Marchand, P. Svatier, D. Bosco, M. Favrot and P.-Y. Benhamou: “Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro”, Stem Cells, Vol. 23, (2005), pp. 594–604.
J.B. Choi, H. Uchino, K. Azuma, N. Iwashita, Y. Tanaka, H. Mochizuki, M. Migita, T. Shimada, R. Kawamori and H. Watada: “Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells”, Diabetologia, Vol. 46, (2003), pp. 1366–1374.
A. Lechner, Y.-Q. Yang, R.A. Blacken, L. Wang, A.L. Nolan and J.F. Habener: “No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo”, Diabetes, Vol. 53, (2004), pp. 616–623.
D. Hess, L. Li, M. Martin, S. Sakano, D. Hill, B. Strutt, S. Thyssen, D.A. Gray and M. Bhatia: “Bone marrow-derived stem cells initiate pancreatic regeneration”, Nat. Biotechnol., Vol. 21, (2003), pp. 763–770.
S.K. Kim and M. Hebrok: “Intercellular signals regulating pancreas development and function”, Genes Develop., Vol. 15, (2001), pp. 11–127.
E. Lammert, O. Cleaver and D. Melton: “Induction of pancreatic differentiation by signals from blood vessels”, Science, Vol. 294, (2001), pp. 564–567.
K. Timper, D. Seboek, M. Eberhardt, P. Linscheid, M. Christ-Crain, U. Keller, B. Muller, H. Zulewski: “Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells”, Biochem. Biophys. Res. Commun., Vol. 341, (2006), pp. 1135–1140.
M. Ruhnke, H. Ungefroren, A. Nussler, F. Martin, M. Brulport, W. Schorman, J.G. Hengstler, W. Klapper, K. Ulrichs, J.A. Hutchinson, B. Soria, R.M. Parwaresch, P. Heeckt, B. Kremer, F. Fändrich: “Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells”, Gastroenterology, Vol. 128, (2005), pp. 1774–1786.
L. Yang, S. Li, H. Hatch, K. Ahrens, J.G. Cornelius, B.E. Petersen and A.B. Peck: “In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells”, Proc. Natl. Acad. Sci. USA, Vol. 99, (2002), pp. 8078–8083.
M.B. Herrera, S. Bruno, S. Buttiglieri, C. Tetta, S. Gatti, M.C. Deregibus, B. Bussolati and G. Camussi: “Isolation and characterization of a stem cell population from adult human liver”, Stem Cells, Vol. 24, (2006), pp. 2840–2850.
S. Efrat: “Prospects for gene therapy of insulin-dependent diabetes mellitus”, Diabetologia, Vol. 41, (1998), pp. 1401–1409.
S. Ferber, A. Halkin, H. Cohen, I. Ber, Y. Einav, I. Goldberg, I. Barshack, R. Seijffers, J. Kopolovic, N. Kaiser and A. Karasik: “Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia”, Nat. Med., Vol. 6, (2000), pp. 568–572.
H. Kojima, M. Fujimiya, K. Matsumura, P. Younan, H. Imaeda, M. Maeda and L. Chan: “NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice”, Nat. Med., Vol. 9, (2003), pp. 596–603.
M. Zalzman, S. Gupta, R.K. Giri, I. Berkovich, B.S. Sappal, O. Karnieli, M.A. Zern, N. Fleischer and S. Efrat: “Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells”, Proc. Natl. Acad. Sci. USA, Vol. 100, (2003), pp. 7253–7258.
H. Kojima, T. Nakamura, Y. Fujita, A. Kishi, M. Fujimiya, S. Yamada, M. Kudo, Y. Nishio, H. Maegawa, M. Haneda, H. Yasuda, I. Kojima, M. Seno, N.C. Wong, R. Kikkawa and A. Kashiwagi: “Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin”, Diabetes, Vol. 51, (2002), pp. 1398–1408.
E. Roche, M.P. Sepulcre, J.A. Reig, A. Santana and B. Soria: “Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells”, FASEB J., Vol. 19, (2005), pp. 1341–1343.
S. Ferron, H. Mira, S. Franco, M. Caro-Jaimez, E. Bellmunt, C. Ramirez, I. Farinas and M.A. Blasco: “Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells”, Development, Vol. 131, (2004), pp. 4059–4070.
A.G. Smith: “Culture and differentiation of embryonic stem cells”, J. Tissue Cult. Meth., Vol. 13, (1991), pp. 89–94.
E. Roche, M.P. Sepulcre, R. Ensenat-Waser, I. Maestre, J.A. Reig and B. Soria: “Bioengineering insulin-secreting cells from embryonic stem cells: a review of progress”, Med. Biol. Engineer. Comp., Vol. 41, (2003), pp. 384–391.
B. Soria, A. Skoudy and F. Martín: “From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus”, Diabetologia, Vol. 44, (2001), pp. 407–415.
A. Shiroi, M. Yoshikawa, H. Yokota, H. Fukui, S. Ishizaka, K. Tatsumi and Y. Takahashi: “Identification of insulin-producing cells derived from embryonic stem cells by zinc-chelating dithizone”, Stem Cells, Vol. 20, (2002), pp. 284–292.
P. Vaca, F. Martin, J.M. Vegara-Meseguer, J.M. Rovira, G. Berna and B. Soria: “Induction of differentiation of embryonic stem cells into insulin secreting cells by fetal soluble factors”, Stem Cells, Vol. 24, (2006), pp. 258–265.
S. Assady, G. Maor, M. Amit, J. Itskovitz-Eldor, K.L. Skorecki and M. Tzukerman: “Insulin production by human embryonic stem cells”, Diabetes, Vol. 50, (2001), pp. 1691–1697.
P. Blyszczuk, J. Czyz, G. Kania, M. Wagner, U. Roll, L. St-Onge, L and A. Wobus: “Expression of Pax4 in embryonic stem cells promotes differentiation of nestinpositive progenitor and insulin-producing cells”, Proc. Natl. Acad. Sci. USA, Vol. 100, (2003), pp. 998–1003.
N. Lumelsky, O. Blondel, P. Laeng, I. Velasco, R. Ravin and R. McKay: “Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets”, Science, Vol. 292, (2001), pp. 1389–1394.
S. Alpert, D. Hanahan and G. Teitelman: “Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons”, Cell, Vol. 53, (1998), pp. 295–308.
C. Vicario-Abejón, M.J. Yusta-Boyo, C. Fernández-Moreno and F. de Pablo: “Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia”, J. Neurosci., Vol. 23, (2003), pp. 895–906.
C. Hernandez-Sanchez, A. Mansilla, E.J. de la Rosa, F. de Pablo: “Proinsulin in development: New roles for an ancient prohormone”, Diabetologia, Vol. 49, (2006), pp. 1142–1150.
D. Melloul, S. Marshak and E. Cerasi: “Regulation of insulin gene transcription”, Diabetologia, Vol. 45, (2002), pp. 309–326.
C. Hernández-Sánchez, A. Mansilla, E.J. de la Rosa, G.E. Pollerberg, E. Martínez-Salas and F. de Pablo: “Upstream AUGs in embryonic proinsulin mRNA control its low translation level”, EMBO J., Vol. 22, (2003), pp. 5582–5592.
K.A. D’Amour, A.D. Agulnick, S. Eliazer, O.G. Kelly, E. Kroon, E.E. Baetge: “Efficient differentiation of human embryonic stem cells to definitive endoderm”, Nat. Biotechnol., Vol. 23, (2005), pp. 1534–1541.
S. Tada, T. Era, C. Furusawa, H. Sakurai, S. Nishikawa, M. Kinoshita, K. Nakao, T. Chiba and S.-I. Nishikawa: “Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture”, Development, Vol. 132, (2005), pp. 4363–4374.
K.A. D’Amour, A.G. Bang, S. Eliazer, O.G. Kelly, A.D. Agulnick, N.G. Smart, M.A. Moorman, E. Kroon, M.K. Carpenter and E.E. Baetge: “Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells”, Nat. Biotechnol., Vol. 24, (2006), pp. 1392–1401.
B. Soria, E. Roche, G. Berna, T. León-Quinto, J.A. Reig and F. Martín: “Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice”, Diabetes, Vol. 49, (2000), pp. 157–162.
M.G. Klug, M.H. Soonpa, G.Y. Koh and L.J. Field: “Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts”, J. Clin. Invest., Vol. 98, (1996), pp. 216–224.
M. Li, L. Pevny, R. Lovell-Badge and A. Smith: “Generation of purified neural precursors from embryonic stem cells by lineage selection”, Curr. Biol., Vol. 8, (1998), pp. 971–974.
M. Müller, B.K. Fleischmann, S. Selbert, G.J. JI, E. Endl, G. Middeler, O.J. Müller, P. Schlenke, S. Frese, A.M. Wobus, J. Hescheler, H.A. Katus and W.M. Franz: “Selection of ventricular-like cardiomyocytes from ES cells in vitro”, FASEB J., Vol. 14, (2000), pp. 2540–2548.
T. León-Quinto, J. Jones, A. Skoudy, M. Burcin and B. Soria: “In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells”, Diabetologia, Vol. 47, (2004), pp. 1442–1451.
S.K. Chakrabarti and R.G. Mirmira: “Transcription factors direct the development and function of pancreatic β cells”, Trends Endocrinol. Metab., Vol. 14, (2003), pp. 78–84.
A. Pattyn, A. Vallstedt, J.M. Dias, M. Sander and J. Ericson: “Complementary roles for Nkx6 and Nkx2 class proteins in the establishment of motoneurons identity in the hindbrain”, Development, Vol. 130, (2003), pp. 4149–4159.
A. Kubo, K. Shinozaki, J.M. Shannon, V. Kouskoff, M. Kennedy, S. Woo, H.J. Fehling and G. Keller: “Development of definitive endoderm from embryonic stem cells in culture”, Development, Vol. 131, (2004), pp. 1651–1662.
M. Yasunaga, S. Tada, S. Torikai-Nishikawa, Y. Nakano, M. Okada, L.M. Jakt, S. Nishikawa, T. Chiba, T. Era and S.-I. Nishikawa: “Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells”, Nat. Biotechnol., Vol. 23, (2005), pp. 1542–1550.
G.K.C. Brolén, N. Heins, J. Edsbagge and H. Semb: “Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulinproducing β-cell-like cells”, Diabetes, Vol. 54, (2005), pp. 2867–2874.
T. Otonkoski, G.M. Beattie, M.I. Mally, C. Ricordi and A. Hayek: “Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells”, J. Clin. Invest., Vol. 92, (1993), pp. 1459–1466.
I. Bai, G. Meredith and B.E. Tuch: “Glucagon-like peptide enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells”, J. Endocrinol., Vol. 186, (2005), pp. 343–352.
Y. Hori, I.C. Rulifson, B.C. Tsai, J.J. Heit, J.D. Cahoy and S.K. Kim: “Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells”, Proc. Natl. Acad. Sci. USA, Vol. 99, (2002), pp. 16105–16110.
H. Noguchi, S. Bonner-Weir, F.Y. Wei, M. Matsushita and S. Matsumoto: “BETA2/NeuroD protein can transduced into cells due to an arginine-and lysisnerich sequence”, Diabetes, Vol. 54, (2005), pp. 2859–2866.
Y. Moritoh, E. Yamato, Y. Yasui, S. Miyazaki and J. Miyazaki: “Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells”, Diabetes, Vol. 52, (2003), pp. 1163–1168.
H. Segev, B. Fishman, A. Ziskind, M. Shulman and J. Itskovitz-Eldor: “Differentiation of human embryonic stem cells into insulin-producing clusters”, Stem Cells, Vol. 22, (2004), pp. 265–274.
M. Polak, L. Bouchareb-Banaei, R. Scharfmann and P. Czernichow: “Early pattern of differentiation in the human pancreas”, Diabetes, Vol. 49, (2000), pp. 225–232.
J. Rajagopal, W.J. Anderson, S. Kume, O.I. Martínez and D.A. Melton: “Insulin staining of ES cell progeny from insulin uptake”, Science, Vol. 299, (2003), p. 363.
H.-J. Paek, J.-R. Morgan and M.J. Lysaght: “Sequestration and synthesis: The source of insulin in cell clusters differentiated from murine embryonic stem cells”, Stem Cells, Vol. 23, (2005), pp. 862–867.
M. Lindgren, M. Hällbrink, A. Prochiantz and Ü. Langel: “Cell-penetrating peptides”, Trends in Pharmacol. Sci., Vol. 21, (2000), pp. 99–103.
H. Noguchi, H. Kaneto, G.C. Weir, S. Bonner-Weir: “Pdx1 protein containing its own antennapedia-like protein transduction domain can transducer pancreatic duct and islet cells”, Diabetes, Vol. 52, (2003), pp. 1732–1737.
J. Dominguez-Bendala, R.L. Pastori, C. Ricordi and L. Inverardi: “Protein transduction: a novel approach to induce in vitro pancreatic differentiation”, Cell. Transplant., Vol. 15 (Suppl. 1), (2006), pp. S85–S90.
H. Noguchi and S. Matsumoto: “Protein transduction technology offers a novel therapeutic approach for diabetes”, J. Hepatobiliary Pancreat. Surg., Vol. 13, (2006), pp. 306–313.
H. Noguchi and S. Matsumoto: “Protein transduction technology: A novel therapeutic perspective”, Acta Med. Okayama, Vol. 60, (2006), pp. 1–11.
P. Collas and A.-M. Hakelien: “Teaching cells new tricks”, Trends Biotechnol., Vol. 21, (2003), pp. 354–361.
A.-M. Hakelien, K.G. Gaustad and P. Collas: “Transient alteration of cell fate using a nuclear and cytoplasmic extract of an insulinoma cell line”, Biochem. Biophys. Res. Commun., Vol. 316, (2004), pp. 834–841.
N. Lavon, O. Yanuka and N. Benvenisty: “The effect of over expression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells”, Stem Cells, Vol. 24, (2006), pp. 1923–1930.
I. Meivar-Levy and S. Ferber: “Rgenerative medicine: using liver to generate pancreas for treating diabetes”, Isr. Med. Assoc. J., Vol. 8, (2006), pp. 430–434.
E.H. Leiter and M. von Herrath: “Animal models have little to teach about type 1 diabetes: 2. In opposition to this proposal”, Diabetologia, Vol. 47, (2004), pp. 1657–1660.
B.O. Roep and M. Atkinson: “Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal”, Diabetologia, Vol. 47, (2004), pp. 1650–1656.
L. Chatenoud: “One step towards restoration of self-tolerance in human autoimmune diseases”, Med. Sci. (Paris), Vol. 23, (2007), pp. 167–172.
C. Ramirez-Castillejo, F. Sanchez-Sanchez, C Andreu-Agullo, S.R. Ferron, J.D. Aroca-Aguilar, P. Sanchez, H. Mira, J. Escribano and I. Farinas: “Pigment epithelium-derived factor is a niche signal for neural stem cell renewal”, Nat. Neurosci., Vol. 9, (2006), pp. 331–339.
S. Miyazaki, E. Yamato and J. Miyazaki: “Regulated expression of Pdx1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells”, Diabetes, Vol. 53, (2004), pp. 1030–1037.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Roche, E., Ramírez, M., Ramírez-Castillejo, C. et al. Stem cell potential for type 1 diabetes therapy. cent.eur.j.biol. 2, 449–480 (2007). https://doi.org/10.2478/s11535-007-0035-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.2478/s11535-007-0035-9